Actualités

CoreWeave Inc (NASDAQ:CRWV) reports second-quarter earnings tonight, with Jefferies maintaining a Buy rating and $150 price target even as it flags that a major profitability inflection is still months away. CoreWeave shares have climbed roughly 45% since hyperscaler earnings reaffirmed...

Analysts have the earnings growing into the price, so what a holder is really underwriting is the build-out that has to produce them.

Tesla Inc. and Space Exploration Technologies Corp. CEO Elon Musk says AI agents could eventually generate vastly more internet traffic than humans, but investor Michael Burry has some questions. Elon Musk Backs AI Traffic Explosion On Sunday, Musk highlighted Cloudflare...

SoFi just posted record loan originations and a 61% jump in net income, yet its stock sits down 30% for the year. Something has to give, and figuring out which side breaks first could be worth 65 cents on every dollar invested.

AI startup Manus said on Tuesday it will ‌resume operating as an independent company ‌and some user data will be deleted as ​part of its separation from U.S. tech giant Meta. • "As part of our transition back to independent operations and to comply ‌with regulatory requirements ⁠in specific jurisdictions, data generated by certain users on/after December ⁠29, 2025" will be deleted later this month, Manus said in a statement. • ​Affected users ​will be notified ​through the Manus ‌app and by email and will be able to back up their data, the company said.

The company pledged to cover its facilities’ energy, water and grid costs as Texas audits a 474 GW interconnection pipeline. Meta disclosed no spending amount, capacity or timetable.

RGTI's Q2 revenues surge 185% as QPU sales and technology gains boost momentum, but heavy losses and uneven demand keep caution in focus.

Rivian's CEO RJ Scaringe is speaking at TechCrunch Disrupt 2026 to detail his journey, and the lessons it’s bestowed.

Investor demand for humanoid robots just shattered records that SpaceX, Snowflake, and Facebook never came close to touching. Here are the five publicly traded robotics stocks best positioned to capture that fever before it cools.

The broad index is now far more expensive than it was before its most recent crash in 2022.

Hims & Hers Health raised its 2026 revenue outlook to between $3.1 billion and $3.3 billion from its earlier guidance between $2.8 billion and $3 billion.

On this episode of Stock Movers: - Anthropic PBC has struck a $9.1 billion deal with Riot Platforms (RIOT), a Bitcoin mining company that recently began selling AI data center capacity. Riot disclosed it had secured a 20-year deal to supply 191 megawatts of capacity from its Rockdale, Texas, campus to a "leading frontier AI" company. - Rocket Lab (RKLB) shares drop as much as 5.7% after the company's Neutron timeline softened, with an analyst saying that while Neutron remains on track to reach launch pad in the fourth quarter, it could push an initial launch to 2027. - Babcock & Wilcox Enterprises (BW) rose in premarket after the company signed an agreement with Siemens Energy to produce steam turbine generator sets. - US-listed shares in On Holding (ONON) drop as much as 17% in premarket trading after the Swiss sneaker maker's second-quarter sales were lower than expected.

European equities traded in the US as American depositary receipts were tracking higher late Tuesday

Healthcare apparel company Figs (NYSE:FIGS) announced better-than-expected revenue in Q2 CY2026, with sales up 28.8% year on year to $196.6 million. Its non-GAAP profit of $0.11 per share was 66.9% above analysts’ consensus estimates.

Two newly public quantum computing companies are about to report earnings. Their results will test the appetite for the budding technology that has captivated some corners of Wall Street.

VRT rides on surging AI data center demand, expanding capacity and advanced power and cooling technologies as it targets further growth.

Can IonQ turn the "quantum is the new AI" hype into a real business by 2031?

RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.

QUBT is shifting from research toward commercial manufacturing, backed by revenue-producing photonics, semiconductor and packaging capabilities.

Recent price strength puts OptimumBank, EuroDry, Enova International, Anika Therapeutics and GEO in focus as August stocks with momentum.

PEP faces pressure from weak North American demand, softer volumes, rising costs and margin headwinds despite its strong global brands.

Plug Power stock jumped after beating earnings estimates.

Voyager stock rallies on a new USSF contract. But does that warrant buying VOYG shares at the current price? Let’s find out!

Riot is scaling its data center push with a 191 MW AI lease, AMD buildout and Corsicana LOI, backed by project debt and $1.2B in liquidity.

Samsung SDI takes full ownership of the Indiana plant as EV demand disappoints

Procter & Gamble (PG) has just updated investors with full year 2027 guidance, new quarterly earnings expectations, and fresh details on capital returns, including dividends and share buybacks, all released alongside its latest annual results. See our latest analysis for Procter & Gamble. At a share price of $146.44, Procter & Gamble has seen a 3.28% year to date share price return, while the 1 year total shareholder return is down 2.73%. This signals momentum that is still relatively muted...

In early August 2026, Costco Wholesale reported July net sales of US$23.12 billion, up 10.7% year over year, and US$273.55 billion in net sales for the first forty‑eight weeks, a 10.1% increase, while brands like Physician's Choice and Mighty Spark Food Company announced nationwide product rollouts across Costco’s U.S. warehouses. These results highlight Costco’s ability to grow high‑volume membership sales while attracting new branded offerings, reinforcing its role as a key distribution...

AbCellera Biologics (NasdaqGS:ABCL) reports positive top line Phase 2 results for ABCL635, its non hormonal antibody treatment for moderate to severe menopausal vasomotor symptoms. The trial shows clinically significant improvement in vasomotor symptoms from a single dose of ABCL635. ABCL635 represents the first clinical success from AbCellera's internal pipeline and supports its GPCR and ion channel antibody discovery platform. The outcome may influence AbCellera's future plans for internal...

Cisco Systems (NasdaqGS: CSCO) is rolling out personalized AI agents to its entire 90,000-person workforce as part of a broad internal transformation. The company is pairing the deployment with major infrastructure investment and company-wide model routing to manage AI workloads across teams and functions. Cisco is setting defined AI-driven revenue targets, tying the internal rollout to measurable business outcomes and new income streams. The move signals a push to use standardized agentic...

KLA Corporation recently declared a quarterly cash dividend of US$0.23 per share, payable on September 1, 2026, to shareholders of record as of August 17, 2026, alongside reporting higher quarterly and full-year revenue and earnings through June 30, 2026, and issuing guidance for the September 2026 quarter. These results and guidance arrive as semiconductor equipment demand is being reinforced by large AI chip manufacturing projects like Tesla and SpaceX’s Terafab complex and by industry...